A hybrid approach based on multiple Eigenvalues selection (MES) for the automated grading of a brain tumor using MRI

The applications of machine learning techniques in medical data processing based on distributed computing and the Internet of Things

Medical data processing has grown into a prominent topic in the latest decades with the primary goal of maintaining patient data via new information technologies, including the Internet of Things (IoT) and sensor technologies, which generate patient indexes in hospital data networks. Innovations like distributed computing, Machine Learning (ML), blockchain, chatbots, wearables, and pattern recognition can adequately enable the collection and processing of medical data for decision-making in the healthcare era. Particularly, to assist experts in the disease diagnostic process, distributed computing is beneficial by digesting huge volumes of data swiftly and producing personalized smart suggestions. On the other side, the current globe is confronting an outbreak of COVID-19, so an early diagnosis technique is crucial to lowering the fatality rate. ML systems are beneficial in aiding radiologists in examining the incredible amount of medical images. Nevertheless, they demand a huge quantity of training data that must be unified for processing. Hence, developing Deep Learning (DL) confronts multiple issues, such as conventional data collection, quality assurance, knowledge exchange, privacy preservation, administrative laws, and ethical considerations. In this research, we intend to convey an inclusive analysis of the most recent studies in distributed computing platform applications based on five categorized platforms, including cloud computing, edge, fog, IoT, and hybrid platforms. So, we evaluated 27 articles regarding the usage of the proposed framework, deployed methods, and applications, noting the advantages, drawbacks, and the applied dataset and screening the security mechanism and the presence of the Transfer Learning (TL) method. As a result, it was proved that most recent research (about 43%) used the IoT platform as the environment for the proposed architecture, and most of the studies (about 46%) were done in 2021. In addition, the most popular utilized DL algorithm was the Convolutional Neural Network (CNN), with a percentage of 19.4%. Hence, despite how technology changes, delivering appropriate therapy for patients is the primary aim of healthcare-associated departments. Therefore, further studies are recommended to develop more functional architectures based on DL and distributed environments and better evaluate the present healthcare data analysis models.

Brain tumor detection and screening using artificial intelligence techniques: Current trends and future perspectives

A brain tumor is an abnormal mass of tissue located inside the skull. In addition to putting pressure on the healthy parts of the brain, it can lead to significant health problems. Depending on the region of the brain tumor, it can cause a wide range of health issues. As malignant brain tumors grow rapidly, the mortality rate of individuals with this cancer can increase substantially with each passing week. Hence it is vital to detect these tumors early so that preventive measures can be taken at the initial stages. Computer-aided diagnostic (CAD) systems, in coordination with artificial intelligence (AI) techniques, have a vital role in the early detection of this disorder. In this review, we studied 124 research articles published from 2000 to 2022. Here, the challenges faced by CAD systems based on different modalities are highlighted along with the current requirements of this domain and future prospects in this area of research.

Performance of deep learning algorithms to distinguish high-grade glioma from low-grade glioma: A systematic review and meta-analysis

This study aims to evaluate deep learning (DL) performance in differentiating low- and high-grade glioma. Search online database for studies continuously published from 1st January 2015 until 16th August 2022. The random-effects model was used for synthesis, based on pooled sensitivity (SE), specificity (SP), and area under the curve (AUC). Heterogeneity was estimated using the Higgins inconsistency index (I²). 33 were ultimately included in the meta-analysis. The overall pooled SE and SP were 94% and 93%, with an AUC of 0.98. There was great heterogeneity in this field. Our evidence-based study shows DL achieves high accuracy in glioma grading. Subgroup analysis reveals several limitations in this field: 1) Diagnostic trials require standard method for data merging for AI; 2) small sample size; 3) poor-quality image preprocessing; 4) not standard algorithm development; 5) not standard data report; 6) different definition of HGG and LGG; and 7) poor extrapolation.

ETISTP: An Enhanced Model for Brain Tumor Identification and Survival Time Prediction

Technology-assisted diagnosis is increasingly important in healthcare systems. Brain tumors are a leading cause of death worldwide, and treatment plans rely heavily on accurate survival predictions. Gliomas, a type of brain tumor, have particularly high mortality rates and can be further classified as low- or high-grade, making survival prediction challenging. Existing literature provides several survival prediction models that use different parameters, such as patient age, gross total resection status, tumor size, or tumor grade. However, accuracy is often lacking in these models. The use of tumor volume instead of size may improve the accuracy of survival prediction. In response to this need, we propose a novel model, the enhanced brain tumor identification and survival time prediction (ETISTP), which computes tumor volume, classifies it into low- or high-grade glioma, and predicts survival time with greater accuracy. The ETISTP model integrates four parameters: patient age, survival days, gross total resection (GTR) status, and tumor volume. Notably, ETISTP is the first model to employ tumor volume for prediction. Furthermore, our model minimizes the computation time by allowing for parallel execution of tumor volume computation and classification. The simulation results demonstrate that ETISTP outperforms prominent survival prediction models.

Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma

Glioma represents a dominant primary intracranial malignancy in the central nervous system. Artificial intelligence that mainly includes machine learning, and deep learning computational approaches, presents a unique opportunity to enhance clinical management of glioma through improving tumor segmentation, diagnosis, differentiation, grading, treatment, prediction of clinical outcomes (prognosis, and recurrence), molecular features, clinical classification, characterization of the tumor microenvironment, and drug discovery. A growing body of recent studies apply artificial intelligence-based models to disparate data sources of glioma, covering imaging modalities, digital pathology, high-throughput multi-omics data (especially emerging single-cell RNA sequencing and spatial transcriptome), etc. While these early findings are promising, future studies are required to normalize artificial intelligence-based models to improve the generalizability and interpretability of the results. Despite prominent issues, targeted clinical application of artificial intelligence approaches in glioma will facilitate the development of precision medicine of this field. If these challenges can be overcome, artificial intelligence has the potential to profoundly change the way patients with or at risk of glioma are provided with more rational care.

A computer-aided grading of glioma tumor using deep residual networks fusion

BACKGROUND AND OBJECTIVES

Among different cancer types, glioma is considered as a potentially fatal brain cancer that arises from glial cells. Early diagnosis of glioma helps the physician in offering effective treatment to the patients. Magnetic Resonance Imaging (MRI)-based Computer-Aided Diagnosis for the brain tumors has attracted a lot of attention in the literature in recent years. In this paper, we propose a novel deep learning-based computer-aided diagnosis for glioma tumors.

METHODS

The proposed method incorporates a two-level classification of gliomas. Firstly, the tumor is classified into low-or high-grade and secondly, the low-grade tumors are classified into two types based on the presence of chromosome arms 1p/19q. The feature representations of four residual networks have been used to solve the problem by utilizing transfer learning approach. Furthermore, we have fused these trained models using a novel Dempster-shafer Theory (DST)-based fusion scheme in order to enhance the classification performance. Extensive data augmentation strategies are also utilized to avoid over-fitting of the discrimination models.

RESULTS

Extensive experiments have been performed on an MRI dataset to show the effectiveness of the method. It has been found that our method achieves 95.87% accuracy for glioma classification. The results obtained by our method have also been compared with different existing methods. The comparative study reveals that our method not only outperforms traditional machine learning-based methods, but it also produces better results to state-of-the-art deep learning-based methods.

CONCLUSION

The fusion of different residual networks enhances the tumor classification performance. The experimental findings indicates that Dempster-shafer Theory (DST)-based fusion technique produces superior performance in comparison to other fusion schemes.

Interpretable Model Based on Pyramid Scene Parsing Features for Brain Tumor MRI Image Segmentation

Due to the black box model nature of convolutional neural networks, computer-aided diagnosis methods based on depth learning are usually poorly interpretable. Therefore, the diagnosis results obtained by these unexplained methods are difficult to gain the trust of patients and doctors, which limits their application in the medical field. To solve this problem, an interpretable depth learning image segmentation framework is proposed in this paper for processing brain tumor magnetic resonance images. A gradient-based class activation mapping method is introduced into the segmentation model based on pyramid structure to visually explain it. The pyramid structure constructs global context information with features after multiple pooling layers to improve image segmentation performance. Therefore, class activation mapping is used to visualize the features concerned by each layer of pyramid structure and realize the interpretation of PSPNet. After training and testing the model on the public dataset BraTS2018, several sets of visualization results were obtained. By analyzing these visualization results, the effectiveness of pyramid structure in brain tumor segmentation task is proved, and some improvements are made to the structure of pyramid model based on the shortcomings of the model shown in the visualization results. In summary, the interpretable brain tumor image segmentation method proposed in this paper can well explain the role of pyramid structure in brain tumor image segmentation, which provides a certain idea for the application of interpretable method in brain tumor segmentation and has certain practical value for the evaluation and optimization of brain tumor segmentation model.

Application of Artificial Intelligence in Diagnosis of Craniopharyngioma

Craniopharyngioma is a congenital brain tumor with clinical characteristics of hypothalamic-pituitary dysfunction, increased intracranial pressure, and visual field disorder, among other injuries. Its clinical diagnosis mainly depends on radiological examinations (such as Computed Tomography, Magnetic Resonance Imaging). However, assessing numerous radiological images manually is a challenging task, and the experience of doctors has a great influence on the diagnosis result. The development of artificial intelligence has brought about a great transformation in the clinical diagnosis of craniopharyngioma. This study reviewed the application of artificial intelligence technology in the clinical diagnosis of craniopharyngioma from the aspects of differential classification, prediction of tissue invasion and gene mutation, prognosis prediction, and so on. Based on the reviews, the technical route of intelligent diagnosis based on the traditional machine learning model and deep learning model were further proposed. Additionally, in terms of the limitations and possibilities of the development of artificial intelligence in craniopharyngioma diagnosis, this study discussed the attentions required in future research, including few-shot learning, imbalanced data set, semi-supervised models, and multi-omics fusion.

Multimodal Disentangled Variational Autoencoder with Game Theoretic Interpretability for Glioma grading

Effective fusion of multimodal magnetic resonance imaging (MRI) is of great significance to boost the accuracy of glioma grading thanks to the complementary information provided by different imaging modalities. However, how to extract the common and distinctive information from MRI to achieve complementarity is still an open problem in information fusion research. In this study, we propose a deep neural network model termed as multimodal disentangled variational autoencoder (MMD-VAE) for glioma grading based on radiomics features extracted from preoperative multimodal MRI images. Specifically, the radiomics features are quantized and extracted from the region of interest for each modality. Then, the latent representations of variational autoencoder for these features are disentangled into common and distinctive representations to obtain the shared and complementary data among modalities. Afterward, cross-modality reconstruction loss and common-distinctive loss are designed to ensure the effectiveness of the disentangled representations. Finally, the disentangled common and distinctive representations are fused to predict the glioma grades, and SHapley Additive exPlanations (SHAP) is adopted to quantitatively interpret and analyze the contribution of the important features to grading. Experimental results on two benchmark datasets demonstrate that the proposed MMD-VAE model achieves encouraging predictive performance (AUC:0.9939) on a public dataset, and good generalization performance (AUC:0.9611) on a cross-institutional private dataset. These quantitative results and interpretations may help radiologists understand gliomas better and make better treatment decisions for improving clinical outcomes.

An improved framework for brain tumor analysis using MRI based on YOLOv2 and convolutional neural network

Brain tumor is a group of anomalous cells. The brain is enclosed in a more rigid skull. The abnormal cell grows and initiates a tumor. Detection of tumor is a complicated task due to irregular tumor shape. The proposed technique contains four phases, which are lesion enhancement, feature extraction and selection for classification, localization, and segmentation. The magnetic resonance imaging (MRI) images are noisy due to certain factors, such as image acquisition, and fluctuation in magnetic field coil. Therefore, a homomorphic wavelet filer is used for noise reduction. Later, extracted features from inceptionv3 pre-trained model and informative features are selected using a non-dominated sorted genetic algorithm (NSGA). The optimized features are forwarded for classification after which tumor slices are passed to YOLOv2-inceptionv3 model designed for the localization of tumor region such that features are extracted from depth-concatenation (mixed-4) layer of inceptionv3 model and supplied to YOLOv2. The localized images are passed toMcCulloch'sKapur entropy method to segment actual tumor region. Finally, the proposed technique is validated on three benchmark databases BRATS 2018, BRATS 2019, and BRATS 2020 for tumor detection. The proposed method achieved greater than 0.90 prediction scores in localization, segmentation and classification of brain lesions. Moreover, classification and segmentation outcomes are superior as compared to existing methods.